Matches in SemOpenAlex for { <https://semopenalex.org/work/W2185349513> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2185349513 abstract "Background Steroid-sensitive nephrotic syndrome (SSNS) in chil-dren is characterized by relapsing courses in a substantial propor-tion of affected individuals. Children with frequent-relapsing neph-rotic syndrome (FRNS) or steroid-dependent nephrotic syndrome(SDNS) are at risk of severe steroid toxicity and need individual-ized treatment. Previous studies have elucidated that cyclophos-phamide (CPA) reduced the risk of relapses and increased thelength of subsequent remissions in children with relapsing SSNS.Methods This retrospective study evaluated 38 patients (26 FRNSand 12 SDNS) after cyclophosphamide therapy to elucidate theefficacy of CPA in FRNS or SDNS in the Department of Child Health,Cipto Mangunkusumo Hospital. All patients were treated with CPA(2 mg/kg per day) for 8 weeks, in combination with prednisone.Results The median (range) duration of follow up was 45 months(24-140 months) for FRNS and 29 months (24-63 months) forSDNS. The mean relapse rate one year prior to CPA therapy inFRNS and SDNS were 3.8 relapses/year (95%CI 3.4; 4.2) and 4.0relapses/year (95%CI 3.3; 4.7), which were reduced to 1.6 relapses/year (95% CI 1.1; 2.1) and 2.3 relapses/year (95%CI 1.5;3.2), re-spectively. The overall rate of cumulative sustained good response(complete remission or infrequent relapses) was 65% after 36months. Frequent relapsing versus steroid-dependent status wassignificantly correlated with rate of sustained good response after36 months (85% versus 15%) with OR=23 (95%CI 3.1;225.2).Conclusion The efficacy of cyclophosphamide therapy in themanagement of FRNS is better than in SDNS" @default.
- W2185349513 created "2016-06-24" @default.
- W2185349513 creator A5030700120 @default.
- W2185349513 creator A5030851782 @default.
- W2185349513 creator A5032302306 @default.
- W2185349513 date "2016-10-10" @default.
- W2185349513 modified "2023-09-26" @default.
- W2185349513 title "Cyclophosphamide in frequent-relapsing or steroid-dependent nephrotic syndrome: Review of 38 patients" @default.
- W2185349513 cites W1542982561 @default.
- W2185349513 cites W1684015277 @default.
- W2185349513 cites W1853153242 @default.
- W2185349513 cites W1967181593 @default.
- W2185349513 cites W1977392594 @default.
- W2185349513 cites W1980517783 @default.
- W2185349513 cites W1996532119 @default.
- W2185349513 cites W2009213096 @default.
- W2185349513 cites W2040766157 @default.
- W2185349513 cites W2101944817 @default.
- W2185349513 cites W2122941588 @default.
- W2185349513 cites W2134425923 @default.
- W2185349513 cites W2336670394 @default.
- W2185349513 cites W2471054539 @default.
- W2185349513 cites W2589372155 @default.
- W2185349513 cites W2888384954 @default.
- W2185349513 cites W3158343500 @default.
- W2185349513 cites W1560763686 @default.
- W2185349513 doi "https://doi.org/10.14238/pi45.1.2005.18-23" @default.
- W2185349513 hasPublicationYear "2016" @default.
- W2185349513 type Work @default.
- W2185349513 sameAs 2185349513 @default.
- W2185349513 citedByCount "1" @default.
- W2185349513 crossrefType "journal-article" @default.
- W2185349513 hasAuthorship W2185349513A5030700120 @default.
- W2185349513 hasAuthorship W2185349513A5030851782 @default.
- W2185349513 hasAuthorship W2185349513A5032302306 @default.
- W2185349513 hasBestOaLocation W21853495131 @default.
- W2185349513 hasConcept C126322002 @default.
- W2185349513 hasConcept C167135981 @default.
- W2185349513 hasConcept C187212893 @default.
- W2185349513 hasConcept C2776694085 @default.
- W2185349513 hasConcept C2776755627 @default.
- W2185349513 hasConcept C2778930706 @default.
- W2185349513 hasConcept C71924100 @default.
- W2185349513 hasConceptScore W2185349513C126322002 @default.
- W2185349513 hasConceptScore W2185349513C167135981 @default.
- W2185349513 hasConceptScore W2185349513C187212893 @default.
- W2185349513 hasConceptScore W2185349513C2776694085 @default.
- W2185349513 hasConceptScore W2185349513C2776755627 @default.
- W2185349513 hasConceptScore W2185349513C2778930706 @default.
- W2185349513 hasConceptScore W2185349513C71924100 @default.
- W2185349513 hasLocation W21853495131 @default.
- W2185349513 hasLocation W21853495132 @default.
- W2185349513 hasOpenAccess W2185349513 @default.
- W2185349513 hasPrimaryLocation W21853495131 @default.
- W2185349513 hasRelatedWork W1504641084 @default.
- W2185349513 hasRelatedWork W1967134323 @default.
- W2185349513 hasRelatedWork W1971771059 @default.
- W2185349513 hasRelatedWork W1977994011 @default.
- W2185349513 hasRelatedWork W1982835221 @default.
- W2185349513 hasRelatedWork W1983663249 @default.
- W2185349513 hasRelatedWork W2021121389 @default.
- W2185349513 hasRelatedWork W2021764303 @default.
- W2185349513 hasRelatedWork W2031746415 @default.
- W2185349513 hasRelatedWork W2043975650 @default.
- W2185349513 hasRelatedWork W2074642663 @default.
- W2185349513 hasRelatedWork W2093007274 @default.
- W2185349513 hasRelatedWork W2141356919 @default.
- W2185349513 hasRelatedWork W2159131535 @default.
- W2185349513 hasRelatedWork W2171579193 @default.
- W2185349513 hasRelatedWork W2331096307 @default.
- W2185349513 hasRelatedWork W2772935562 @default.
- W2185349513 hasRelatedWork W2885165956 @default.
- W2185349513 hasRelatedWork W2955164378 @default.
- W2185349513 hasRelatedWork W2994322074 @default.
- W2185349513 isParatext "false" @default.
- W2185349513 isRetracted "false" @default.
- W2185349513 magId "2185349513" @default.
- W2185349513 workType "article" @default.